valtrex
glaxosmithkline nz limited - valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg; ; valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg - film coated tablet - 500 mg - active: valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg excipient: carnauba wax colloidal silicon dioxide crospovidone edible ink blue brilliant 5312 magnesium stearate microcrystalline cellulose opadry white ys1-18043 povidone purified water active: valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg excipient: carnauba wax colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white ys1-18043 povidone purified water - · valtrex is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.
zeffix
glaxosmithkline nz limited - lamivudine 100mg; - film coated tablet - 100 mg - active: lamivudine 100mg excipient: magnesium stearate opadry butterscotch ys-1r-17307-a powdered cellulose sodium starch glycolate - zeffix is indicated for the treatment of adults and children aged 2 years and older with chronic hepatitis b and evidence of hepatitis b viruse (hbv) replication.
zovirax ophthalmic
glaxosmithkline nz limited - aciclovir 3%{relative} - eye ointment - 3% w/w - active: aciclovir 3%{relative} excipient: white soft paraffin - treatment of herpes simplex keratitis.
betnovate n
glaxo laboratories limited - betamethasone valerate neomycin sulfate - ointment - 0.1/0.5 %w/w
ceporex granules for oral suspension 125 mg/5ml mg/5ml
glaxo laboratories limited - cefalexin - granules for oral suspension - 125 mg/5ml mg/5ml
ceporex granules for oral suspension 250 mg/5 mg/5ml
glaxo laboratories limited - cefalexin - granules for oral suspension - 250 mg/5 mg/5ml
betnovate n 0.1/0.5 %w/w ointment
glaxo laboratories limited - betamethasone valerate neomycin sulfate - ointment - 0.1/0.5 %w/w
ceporex 250 mg/5 mg/5ml granules for oral suspension
glaxo laboratories limited - cefalexin - granules for oral suspension - 250 mg/5 mg/5ml
ceporex 125 mg/5ml mg/5ml granules for oral suspension
glaxo laboratories limited - cefalexin - granules for oral suspension - 125 mg/5ml mg/5ml
imigran
glaxosmithkline nz limited - sumatriptan succinate 16.8 mg/ml; - solution for injection - 6 mg/0.5ml - active: sumatriptan succinate 16.8 mg/ml - imigran injection is indicated for the acute relief of migraine attacks with or without aura, and for the acute treatment of cluster headache.